Visfatin protein expression is primarily localized around the central vein in hepatic lobules exhibiting mild steatosis. Elevated levels of Visfatin in serum and liver tissue appear early in the disease progression, suggesting its potential involvement in the pathogenesis of NAFLD. This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatotic liver disease.